Research Article 
Blood pressure control and awareness among patients with diabetes and hypertension attending a tertiary ophthalmic clinic
N. Wong, S. S. Wang, E. Lamoureux, T. Y. Wong, G. Tikellis, A. Harper and J. J. Wang
Diabetic Medicine, 2009, 26(1), 34-39. DOI: 10.1111/j.1464-5491.2008.02614.x
Abstract
Aims To assess the proportion of patients who had diabetes and hypertension with optimal blood pressure (BP) control and to describe patients' awareness of the importance of BP control.
Methods A cross-sectional survey of out-patients with diabetes who attended the Royal Victorian Eye and Ear Hospital (Melbourne, Australia) was conducted between October 2006 and February 2007. Of 245 patients invited, 220 (90%) participated. Optimal BP control was defined as BP < 130/80 mmHg recorded at the latest visit; proportions of patients with awareness of BP control were defined non-exclusively by: (i) ability to recall a previous BP record and rate the appropriateness of that BP level; (ii) ability to recall the recommended optimal BP control level by current diabetes management guidelines; (iii) knowledge that optimal BP control is important to diabetes management; and (iv) knowledge that optimal BP control is important to eye health.
Results Of the 220 patients, 176 had both diabetes and hypertension. Of these, 49 of 176 (28%) had BP controlled optimally, and 30 of 176 (17%) recalled and rated a previous recorded BP level appropriately. Fewer than one in four (22%) acknowledged the recommended optimum BP level of < 130/80 mmHg, fewer than one in two (48%) rated BP as important to diabetes management, and one in three (35%) rated BP control as important to eye health.
Conclusions In this sample of patients with diabetes and hypertension, fewer than one-third achieved the BP level recommended by clinical guidelines, and fewer than half were aware of the importance of BP control.
ASCI-ID: 109-532
Similar Articles
Nurse-led clinics for strict hypertension control are effective long term: a 7 year follow-up study
Diabetic Medicine, 2010, 27(8), 933-937. DOI: 10.1111/j.1464-5491.2010.03039.x
Risk factors for diabetic retinopathy in a South Indian Type 2 diabetic population—the Chennai Urban Rural Epidemiology Study (CURES) Eye Study 4Diabetic Medicine, 2008, 25(5), 536-542. DOI: 10.1111/j.1464-5491.2008.02423.x
Health utility values associated with diabetic retinopathyDiabetic Medicine, 2008, 25(5), 618-624. DOI: 10.1111/j.1464-5491.2008.02430.x
The Y402H variant of complement factor H is associated with age-related macular degeneration but not with diabetic retinal disease in the Go-DARTS studyDiabetic Medicine, 2009, 26(5), 460-465. DOI: 10.1111/j.1464-5491.2009.02719.x
Long-term impact of retinal screening on significant diabetes-related visual impairment in the working age populationDiabetic Medicine, 2009, 26(5), 489-492. DOI: 10.1111/j.1464-5491.2009.02718.x
Trends in yield and effects of screening intervals during 17 years of a large UK community-based diabetic retinopathy screening programmeDiabetic Medicine, 2009, 26(10), 1040-1047. DOI: 10.1111/j.1464-5491.2009.02820.x
Pregnancy-induced sight-threatening diabetic retinopathy in women with Type 1 diabetesDiabetic Medicine, 2010, 27(4), 431-435.
Is risk of diabetic retinopathy lower in Australia’s Greek-born migrants?Diabetic Medicine, 2010, 27(6), 660-665. DOI: 10.1111/j.1464-5491.2010.03005.x
Retinal microaneurysm count predicts progression and regression of diabetic retinopathy. Post-hoc results from the DIRECT ProgrammeDiabetic Medicine, 2011, 28(3), 345-351. DOI: 10.1111/j.1464-5491.2010.03210.x
Increased levels of monokine induced by interferon-γ (Mig) in the vitreous of patients with diabetic retinopathyDiabetic Medicine, 2008, 25(7), 875-877. DOI: 10.1111/j.1464-5491.2008.02466.x
Reliability of screening methods for diabetic retinopathyDiabetic Medicine, 2009, 26(8), 783-790. DOI: 10.1111/j.1464-5491.2009.02778.x
Diabetic retinopathy screening: a systematic review of the economic evidenceDiabetic Medicine, 2010, 27(3), 249-256. DOI: 10.1111/j.1464-5491.2009.02870.x
Socio-economic and ethnic inequalities in diabetes retinal screeningDiabetic Medicine, 2010, 27(3), 282-288. DOI: 10.1111/j.1464-5491.2010.02946.x
Association between alcohol consumption and diabetic retinopathy and visual acuity-the AdRem StudyDiabetic Medicine, 2010, 27(10), 1130-1137. DOI: 10.1111/j.1464-5491.2010.03080.x
Agreement and reasons for disagreement between photographic and hospital biomicroscopy grading of diabetic retinopathyDiabetic Medicine, 2011, 28(6), 741-746. DOI: 10.1111/j.1464-5491.2011.03273.x
Do type 2 diabetes patients without diabetic retinopathy or subjects with impaired fasting glucose have impaired colour vision? The Okubo Color Study ReportDiabetic Medicine, 2011, 28(7), 865-871. DOI: 10.1111/j.1464-5491.2011.03290.x
External quality assurance for image grading in the Scottish Diabetic Retinopathy Screening ProgrammeDiabetic Medicine, 2012, 29(6), 776-783. DOI: 10.1111/j.1464-5491.2011.03504.x
Preferences of people with diabetes for diabetic retinopathy screening: a discrete choice experimentDiabetic Medicine, 2012, 29(7), 869-877. DOI: 10.1111/j.1464-5491.2012.03636.x
Diabetic retinopathy screening: perspectives of people with diabetes, screening intervals and costs of attending screeningDiabetic Medicine, 2012, 29(7), 878-885. DOI: 10.1111/j.1464-5491.2012.03637.x
Prevalence of diabetic retinopathy in Type 2 diabetes in developing and developed countriesDiabetic Medicine, 2013, 30(4), 387-398. DOI: 10.1111/dme.12119
Comparison of vildagliptin and acarbose monotherapy in patients with Type 2 diabetes: a 24-week, double-blind, randomized trialDiabetic Medicine, 2008, 25(4), 435-441. DOI: 10.1111/j.1464-5491.2008.02391.x
Long-term efficacy and safety of insulin detemir compared to Neutral Protamine Hagedorn insulin in patients with Type 1 diabetes using a treat-to-target basal-bolus regimen with insulin aspart at meals: a 2-year, randomized, controlled trialDiabetic Medicine, 2008, 25(4), 442-449. DOI: 10.1111/j.1464-5491.2007.02407.x
Rosiglitazone RECORD study: glucose control outcomes at 18 monthsDiabetic Medicine, 2007, 24(6), 626-634. DOI: 10.1111/j.1464-5491.2007.02160.x
Comparison of insulin detemir and insulin glargine in subjects with Type 1 diabetes using intensive insulin therapyDiabetic Medicine, 2007, 24(6), 635-642. DOI: 10.1111/j.1464-5491.2007.02113.x
Offspring birth weight, gestational age and maternal characteristics in relation to glucose status at age 53 years: evidence from a national birth cohortDiabetic Medicine, 2008, 25(5), 530-535. DOI: 10.1111/j.1464-5491.2008.02427.x
An effective system of nurse-led diabetes care in rural AfricaDiabetic Medicine, 2008, 25(5), 606-611. DOI: 10.1111/j.1464-5491.2008.02421.x
Relative and absolute contributions of postprandial and fasting plasma glucose to daytime hyperglycaemia and HbA1c in subjects with Type 2 diabetesDiabetic Medicine, 2009, 26(10), 974-980. DOI: 10.1111/j.1464-5491.2009.02809.x
Improving glycaemic control in children and adolescents: which aspects of therapy really matter?Diabetic Medicine, 2010, 27(4), 369-375. DOI: 10.1111/j.1464-5491.2009.02895.x
Persistent individual tracking within overall improvement in HbA1c in a UK paediatric diabetes clinic over 15 yearsDiabetic Medicine, 2010, 27(11), 1284-1288. DOI: 10.1111/j.1464-5491.2010.03057.x
Prevalence of injection-meal interval usage and its association with variables of metabolic control in patients with Type 1 and Type 2 diabetesDiabetic Medicine, 2011, 28(2), 223-226. DOI: 10.1111/j.1464-5491.2010.03172.x
Disturbed vibrotactile sense in finger pulps in patients with Type 1 diabetes−correlations with glycaemic level, clinical examination and electrophysiologyDiabetic Medicine, 2011, 28(9), 1045-1052. DOI: 10.1111/j.1464-5491.2011.03328.x
Behaviour and metabolic control in children with Type 1 diabetes mellitus on insulin pump therapy: 2-year follow-upDiabetic Medicine, 2011, 28(9), 1109-1112. DOI: 10.1111/j.1464-5491.2011.03322.x
Diabetes inpatients: a case of lose, lose, lose. Is it time to use a ‘diabetes-attributable hospitalization cost’ to assess the impact of diabetes?Diabetic Medicine, 2011, 28(9), 1123-1130. DOI: 10.1111/j.1464-5491.2011.03295.x
Reduction in glycated albumin can predict change in HbA1c: comparison of oral hypoglycaemic agent and insulin treatmentsDiabetic Medicine, 2012, 29(1), 74-79. DOI: 10.1111/j.1464-5491.2011.03386.x
Predictive value of HbA1c for incident diabetes among subjects with impaired glucose tolerance—analysis of the Indian Diabetes Prevention ProgrammesDiabetic Medicine, 2012, 29(1), 94-98. DOI: 10.1111/j.1464-5491.2011.03392.x
Cut-off values of fasting and post-load plasma glucose and HbA1c for predicting Type 2 diabetes in community-dwelling Japanese subjects: the Hisayama StudyDiabetic Medicine, 2012, 29(1), 99-106. DOI: 10.1111/j.1464-5491.2011.03378.x
Comparison of continuous subcutaneous insulin infusion (CSII) and multiple daily injections (MDI) in paediatric Type 1 diabetes: a multicentre matched-pair cohort analysis over 3 yearsDiabetic Medicine, 2008, 25(1), 80-85. DOI: 10.1111/j.1464-5491.2007.02311.x
Can we predict future improvement in glycaemic control?Diabetic Medicine, 2008, 25(2), 170-173. DOI: 10.1111/j.1464-5491.2007.02309.x
Relationship between mean blood glucose and glycated haemoglobin in Type 2 diabetic patientsDiabetic Medicine, 2008, 25(2), 174-178. DOI: 10.1111/j.1464-5491.2007.02379.x
Glycaemic control and body mass index in late-adolescents and young adults with Type 1 diabetes mellitus: a population-based studyDiabetic Medicine, 2008, 25(3), 360-364. DOI: 10.1111/j.1464-5491.2007.02372.x
A proposal for a role of HbA1c in screening for gestational diabetesDiabetic Medicine, 2009, 26(8), 833-834. DOI: 10.1111/j.1464-5491.2009.02777.x
Adherence to a Mediterranean diet and glycaemic control in Type 2 diabetes mellitusDiabetic Medicine, 2009, 26(9), 900-907. DOI: 10.1111/j.1464-5491.2009.02798.x
Skeletal muscle microvascular exchange capacity is associated with hyperglycaemia in subjects with central obesityDiabetic Medicine, 2009, 26(11), 1112-1119. DOI: 10.1111/j.1464-5491.2009.02822.x
Ramadan Education and Awareness in Diabetes (READ) programme for Muslims with Type 2 diabetes who fast during RamadanDiabetic Medicine, 2010, 27(3), 327-331. DOI: 10.1111/j.1464-5491.2010.02948.x
HbA1c for diabetes diagnosis. Are we ready?Diabetic Medicine, 2010, 27(3), 367-368. DOI: 10.1111/j.1464-5491.2010.02942.x
For debate.Glucose variability and diabetes complication risk: we need to know the answerDiabetic Medicine, 2010, 27(8), 868-871. DOI: 10.1111/j.1464-5491.2010.02929.x
Glycated haemoglobin and blood pressure-lowering effect of cinnamon in multi-ethnic Type 2 diabetic patients in the UK: a randomized, placebo-controlled, double-blind clinical trialDiabetic Medicine, 2010, 27(10), 1159-1167. DOI: 10.1111/j.1464-5491.2010.03079.x
Glycated haemoglobin A1c (HbA1c) in the diagnosis of diabetes mellitus: don't forget the performance of the HbA1c assayDiabetic Medicine, 2010, 27(10), 1214-1215. DOI: 10.1111/j.1464-5491.2010.03088.x
Efficacy and safety of the dipeptidyl peptidase-4 inhibitor PF-734200 added to metformin in Type 2 diabetesDiabetic Medicine, 2011, 28(4), 464-469. DOI: 10.1111/j.1464-5491.2010.03181.x
What would be the outcome if the American Diabetes Association recommendations of 2010 had been followed in our pratice in 1998-2006?Diabetic Medicine, 2011, 28(5), 567-574. DOI: 10.1111/j.1464-5491.2010.03215.x
Asymmetric dimethylarginine in young people with Type 1 diabetes: a paradoxical association with HbA1cDiabetic Medicine, 2011, 28(6), 685-691. DOI: 10.1111/j.1464-5491.2011.03252.x
The association between anxiety and measures of glycaemia in a population-based diabetes screening programmeDiabetic Medicine, 2011, 28(7), 785-788. DOI: 10.1111/j.1464-5491.2011.03245.x
ROSES: role of self-monitoring of blood glucose and intensive education in patients with Type 2 diabetes not receiving insulin. A pilot randomized clinical trialDiabetic Medicine, 2011, 28(7), 789-796. DOI: 10.1111/j.1464-5491.2011.03268.x
Glycaemic control is positively associated with prevalent fractures but not with bone mineral density in patients with Type 1 diabetesDiabetic Medicine, 2011, 28(7), 872-875. DOI: 10.1111/j.1464-5491.2011.03286.x
Diabetes Medication Assistance Service Stage 1: impact and sustainability of glycaemic and lipids control in patients with Type 2 diabetesDiabetic Medicine, 2011, 28(8), 987-993. DOI: 10.1111/j.1464-5491.2011.03296.x
Effect of sitagliptin on glucose control in adult patients with Type 1 diabetes: a pilot, double-blind, randomized, crossover trialDiabetic Medicine, 2011, 28(10), 1176-1181. DOI: 10.1111/j.1464-5491.2011.03331.x
Shifting from glucose diagnostic criteria to the new HbA1c criteria would have a profound impact on prevalence of diabetes among a high-risk Spanish populationDiabetic Medicine, 2011, 28(10), 1234-1237. DOI: 10.1111/j.1464-5491.2011.03304.x
Illness perceptions and glycaemic control in diabetes: a systematic review with meta-analysisDiabetic Medicine, 2011, 28(11), 1300-1310. DOI: 10.1111/j.1464-5491.2011.03298.x
A first national prevalence estimate of diagnosed and undiagnosed diabetes in France in 18- to 74-year-old individuals: the French Nutrition and Health Survey 2006/2007Diabetic Medicine, 2011, 28(5), 583-589. DOI: 10.1111/j.1464-5491.2011.03250.x
Comparing incident diabetes as defined by fasting plasma glucose or by HbA1c. The AusDiab, Inter99 and DESIR studiesDiabetic Medicine, 2011, 28(11), 1311-1318. DOI: 10.1111/j.1464-5491.2011.03403.x
HbA1c 3 months after diagnosis predicts premature mortality in patients with new onset type 2 diabetesDiabetic Medicine, 2011, 28(12), 1520-1524. DOI: 10.1111/j.1464-5491.2011.03443.x
Comparison of longitudinal point-of-care and high-performance liquid chromatography HbA1c measurements in a multi-centre trialDiabetic Medicine, 2011, 28(12), 1525-1529. DOI: 10.1111/j.1464-5491.2011.03404.x
Time trends in absolute and modifiable coronary heart disease risk in patients with Type 2 diabetes in the Swedish National Diabetes Register (NDR) 2003-2008Diabetic Medicine, 2012, 29(2), 198-206. DOI: 10.1111/j.1464-5491.2011.03425.x
Establishing an evidence base for frequency of monitoring glycated haemoglobin levels in patients with Type 2 diabetes: projections of effectiveness from a regression modelDiabetic Medicine, 2012, 29(2), 266-271. DOI: 10.1111/j.1464-5491.2011.03412.x
HbA1c in the diagnosis of diabetes: which cut-off point?Diabetic Medicine, 2012, 29(2), 286-287. DOI: 10.1111/j.1464-5491.2011.03397.x
Association between HbA1c and cardiovascular disease mortality in older Hong Kong Chinese with diabetesDiabetic Medicine, 2012, 29(3), 393-398. DOI: 10.1111/j.1464-5491.2011.03456.x
Hypoglycaemia during pregnancy in women with Type 1 diabetesDiabetic Medicine, 2012, 29(5), 558-566. DOI: 10.1111/j.1464-5491.2012.03604.x
Effects of rosuvastatin and atorvastatin on glycaemic control in Type 2 diabetes-the CORALL studyDiabetic Medicine, 2012, 29(5), 628-631. DOI: 10.1111/j.1464-5491.2011.03553.x
Differences in the quality of diabetes care caused by social inequalities disappear after treatment and education in a tertiary care centreDiabetic Medicine, 2012, 29(5), 640-645. DOI: 10.1111/j.1464-5491.2011.03455.x
Poor numeracy skills are associated with glycaemic control in Type 1 diabetesDiabetic Medicine, 2012, 29(5), 662-669. DOI: 10.1111/j.1464-5491.2011.03466.x
The relationship between HbA1c and fasting plasma glucose in patients with increased plasma liver enzyme measurementsDiabetic Medicine, 2012, 29(6), 742-747. DOI: 10.1111/j.1464-5491.2011.03543.x
A simple strategy for screening for glucose intolerance, using glycated haemoglobin, in individuals admitted with acute coronary syndromeDiabetic Medicine, 2012, 29(7), 838-843. DOI: 10.1111/j.1464-5491.2012.03643.x
Haemoglobin A1c cut-off point to identify a high risk group of future diabetes: results from the Omiya MA Cohort StudyDiabetic Medicine, 2012, 29(7), 905-910. DOI: 10.1111/j.1464-5491.2012.03572.x
Fasting plasma glucose 6-12 weeks after starting insulin glargine predicts likelihood of treatment success: a pooled analysisDiabetic Medicine, 2012, 29(7), 933-936. DOI: 10.1111/j.1464-5491.2012.03640.x
High normal HbA1c levels were associated with impaired insulin secretion without escalating insulin resistance in Japanese individuals: the Toranomon Hospital Health Management Center Study 8 (TOPICS 8)Diabetic Medicine, 2012, 29(10), 1285-1290. DOI: 10.1111/j.1464-5491.2012.03667.x
Finally, a UK consensus on the use of HbA1c to diagnose diabetesDiabetic Medicine, 2012, 29(11), 1349-1349. DOI: 10.1111/dme.12011
Use of HbA1c in the diagnosis of diabetes mellitus in the UK. The implementation of World Health Organization guidance 2011Diabetic Medicine, 2012, 29(11), 1350-1357. DOI: 10.1111/j.1464-5491.2012.03762.x
HbA1c-based diabetes diagnosis among patients with glucokinase mutation (GCK-MODY) is affected by a genetic variant of glucose-6-phosphatase (G6PC2)Diabetic Medicine, 2012, 29(11), 1465-1469. DOI: 10.1111/j.1464-5491.2012.03671.x
Intrapersonal HbA1c variability and the risk of progression of nephropathy in patients with Type 2 diabetesDiabetic Medicine, 2012, 29(12), 1562-1566. DOI: 10.1111/j.1464-5491.2012.03767.x
Area-under-the-HbA1c-curve above the normal range and the prediction of microvascular outcomes: an analysis of data from the Diabetes Control and Complications TrialDiabetic Medicine, 2013, 30(1), 95-99. DOI: 10.1111/dme.12004
The impact of blood glucose and HbA1c goals on glycaemic control in children and adolescents with Type 1 diabetesDiabetic Medicine, 2013, 30(3), 333-337. DOI: 10.1111/dme.12083
Insulin-dose-adjusted HbA1c-defined partial remission phase in a paediatric population-when is the honeymoon over?Diabetic Medicine, 2013, 30(5), 627-628. DOI: 10.1111/dme.12097
Prevalence of diabetes in Malaysia and usefulness of HbA1c as a diagnostic criterionDiabetic Medicine, 2013, 30(7), 825-828. DOI: 10.1111/dme.12161
Feedback of personal retinal images appears to have a motivational impact in people with non-proliferative diabetic retinopathy and suboptimal HbA1c: findings of a pilot studyDiabetic Medicine, 2013, 30(9), 1122-1125. DOI: 10.1111/dme.12192
Improved post-partum follow-up of patients with gestational diabetes mellitus using HbA1cDiabetic Medicine, 2013, 30(10), 1264-1265. DOI: 10.1111/dme.12279
Relationship between HbA1c and risk of all-cause hospital admissions among people with Type 2 diabetesDiabetic Medicine, 2013, 30(12), 1407-1411. DOI: 10.1111/dme.12235
Association of pain with HbA1c in a predominantly black population of community-dwelling adults with diabetes: a cross-sectional analysisDiabetic Medicine, 2013, 30(12), 1466-1471. DOI: 10.1111/dme.12264
Positivity for islet cell autoantibodies in patients with monogenic diabetes is associated with later diabetes onset and higher HbA1c levelDiabetic Medicine, 2014, 31(4), 466-471. DOI: 10.1111/dme.12314
Depressive symptoms and HbA1c in patients with Type 1 and Type 2 diabetesDiabetic Medicine, 2014, 31(6), 759-760. DOI: 10.1111/dme.12419
Establishing HbA1c-mean blood glucose formulae for patients on continuous ambulatory peritoneal dialysisDiabetic Medicine, 2014, 31(7), 813-820. DOI: 10.1111/dme.12432
Individualizing HbA1c targets for patients with diabetes: impact of an automated algorithm within a primary care networkDiabetic Medicine, 2014, 31(7), 839-846. DOI: 10.1111/dme.12427
Aging is associated with increased HbA1c levels, independently of glucose levels and insulin resistance, and also with decreased HbA1c diagnostic specificityDiabetic Medicine, 2014, 31(8), 927-935. DOI: 10.1111/dme.12459
Cardiovascular risk profiles in relation to newly diagnosed Type 2 diabetes diagnosed by either glucose or HbA1c criteria in Chinese adults in Qingdao, ChinaDiabetic Medicine, 2014, 31(8), 920-926. DOI: 10.1111/dme.12498